Alternative Splicing of Cyr61 Is Regulated by Hypoxia and Significantly Changed in Breast Cancer

Hypoxia — a key regulatory factor in tumour growth

Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177 · see citing works

Mechanisms of Alternative Pre-Messenger RNA Splicing

Black, D. L. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161720 · Cited by 2,704 · see citing works

Understanding alternative splicing: towards a cellular code

Matlin, A. J., Clark, F., & Smith, C. W. J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1645 · Cited by 1,299 · see citing works

Alternative Splicing: New Insights from Global Analyses

Blencowe, B. J. (2006) · Cell · doi:10.1016/j.cell.2006.06.023 · Cited by 1,122 · see citing works

CCN proteins: multifunctional signalling regulators

Perbal, B. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15172-0 · Cited by 704 · see citing works

All in the CCN family: essential matricellular signaling modulators emerge from the bunker

Leask, A., & Abraham, D. (2006) · Journal of Cell Science · doi:10.1242/jcs.03270 · Cited by 653 · see citing works

The CCN Family of Angiogenic Regulators: The Integrin Connection

Lau, L. F., & Lam, S. C.-T. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4456 · Cited by 645 · see citing works

Aberrant and Alternative Splicing in Cancer

Venables, J. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1910 · Cited by 630 · see citing works

The modular architecture of a new family of growth regulators related to connective tissue growth factor

Peer Bork, B. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80155-n · Cited by 623 · see citing works

The Connective Tissue Growth Factor/Cysteine- Rich 61/Nephroblastoma Overexpressed (CCN) Family

Brigstock, D. R. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.2.0360 · Cited by 588 · see citing works

Protein Diversity from Alternative Splicing

Black, D. L. (2000) · Cell · doi:10.1016/s0092-8674(00)00128-8 · Cited by 565 · see citing works

RNA binding specificity of hnRNP A1: significance of hnRNP A1 high‐affinity binding sites in pre‐mRNA splicing.

Burd, C. G., & Dreyfuss, G. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06369.x · Cited by 488 · see citing works

A quantitative analysis of intron effects on mammalian gene expression

Nott, A., MEISLIN, S. H., & Moore, M. J. (2003) · RNA · doi:10.1261/rna.5250403 · Cited by 417 · see citing works

The Connective Tissue Growth Factor/Cysteine- Rich 61/Nephroblastoma Overexpressed (CCN) Family

Brigstock, D. R. (1999) · Endocrine Reviews · doi:10.1210/er.20.2.189 · Cited by 370 · see citing works

NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues

Perbal, B. (2001) · Molecular Pathology · doi:10.1136/mp.54.2.57 · Cited by 345 · see citing works

Cyr61, a Product of a Growth Factor-Inducible Immediate-Early Gene, Promotes Cell Proliferation, Migration, and Adhesion

Kireeva, M. L., Mo, F.-E., Yang, G. P., & Lau, L. F. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1326 · Cited by 341 · see citing works

The evolving roles of alternative splicing

Lareau, L. F., Green, R. E., Bhatnagar, R. S., & Brenner, S. E. (2004) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2004.05.002 · Cited by 315 · see citing works

Expression of cyr61, a growth factor-inducible immediate-early gene.

O'Brien, T. P., Yang, G. P., Sanders, L., & Lau, L. F. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.7.3569 · Cited by 310 · see citing works

Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61)

Brigstock, D. R. (2002) · Angiogenesis · doi:10.1023/a:1023823803510 · Cited by 300 · see citing works

CCN1/Cyr61 Is Regulated by the Canonical Wnt Signal and Plays an Important Role in Wnt3A-Induced Osteoblast Differentiation of Mesenchymal Stem Cells

Si, W., Kang, Q., Luu, H. H., Park, J. K., Luo, Q., Song, W.-X., Jiang, W., Luo, X., Li, X., Yin, H., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.2955-2964.2006 · Cited by 272 · see citing works

Alternative splicing: an emerging topic in molecular and clinical oncology

Pajares, M. J., Ezponda, T., Catena, R., Calvo, A., Pı́o, R., & Montuenga, L. M. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70104-3 · Cited by 261 · see citing works

Pro-angiogenic Activities of CYR61 (CCN1) Mediated through Integrins αvβ3 and α6β1 in Human Umbilical Vein Endothelial Cells

Leu, S.-J., Lam, S. C.-T., & Lau, L. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209288200 · Cited by 247 · see citing works

Cyr61 and Fisp12 Are Both ECM-Associated Signaling Molecules: Activities, Metabolism, and Localization during Development

Kireeva, M. L., Latinkic, B., Kolesnikova, T. V., Chen, C.-C., Yang, G. P., Abler, A. S., & Lau, L. F. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3548 · Cited by 236 · see citing works

Detection and evaluation of intron retention events in the human transcriptome

Galante, P. A. F., Sakabe, N. J., Kirschbaum-Slager, N., & SOUZA, S. J. D. (2004) · RNA · doi:10.1261/rna.5123504 · Cited by 228 · see citing works

Alternative splicing in cancer: Noise, functional, or systematic?

Skotheim, R. I., & Nees, M. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.02.016 · Cited by 208 · see citing works

The RNA binding protein YB‐1 binds A/C‐rich exon enhancers and stimulates splicing of the CD44 alternative exon v4

Stickeler, E., Fraser, S. D., Honig, A., Chen, A. L., Berget, S. M., & Cooper, T. A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.14.3821 · Cited by 196 · see citing works

Cyr61 Expression Confers Resistance to Apoptosis in Breast Cancer MCF-7 Cells by a Mechanism of NF-κB-dependent XIAP Up-Regulation

Lin, M.-T., Chang, C.-C., Chen, S.-T., Chang, H.-L., Su, J.-L., Chau, Y.-P., & Kuo, M.-L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402305200 · Cited by 194 · see citing works

Molecular responses to hypoxia in tumor cells.

Kunz, M., & Ibrahim, S. M. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-23 · Cited by 192 · see citing works

Cyr61 promotes breast tumorigenesis and cancer progression

Tsai, M.-S., Bogart, D. F., Castañeda, J. M., Li, P., & Lupu, R. (2002) · Oncogene · doi:10.1038/sj.onc.1205682 · Cited by 189 · see citing works

Cyr61, product of a growth factor-inducible immediate early gene, is associated with the extracellular matrix and the cell surface.

Yang, G. P., & Lau, L. F. (1991) · PubMed · Cited by 187 · see citing works

Levels of Expression of CYR61 and CTGF Are Prognostic for Tumor Progression and Survival of Individuals with Gliomas

Xie, D., Yin, D., Wang, H., Liu, G., Elashoff, R. M., Black, K. L., & Koeffler, H. P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0659-03 · Cited by 179 · see citing works

Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis

Stickeler, E., Kittrell, F. S., Medina, D., & Berget, S. M. (1999) · Oncogene · doi:10.1038/sj.onc.1202671 · Cited by 175 · see citing works

Functional properties and intracellular signaling of CCN1/Cyr61

Chen, Y., & Du, X. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21194 · Cited by 167 · see citing works

Sequence features responsible for intron retention in human

Sakabe, N. J., & de Souza, S. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-59 · Cited by 164 · see citing works

An Alternative-Exon Database and Its Statistical Analysis

Stamm, S., Zhu, J., Nakai, K., Stoilov, P., Stoß, O., & Zhang, M. Q. (2000) · DNA and Cell Biology · doi:10.1089/104454900750058107 · Cited by 156 · see citing works

The Yeast hnRNP-like Protein Hrp1/Nab4 Marks a Transcript for Nonsense-Mediated mRNA Decay

Gonzalez, C. I., Ruiz-Echevarría, M. J., Vasudevan, S., Henry, M. F., & Peltz, S. W. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80443-8 · Cited by 155 · see citing works

A novel CYR61-triggered ‘CYR61-αvβ3 integrin loop’ regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway

Menendez, J. A., Vellon, L., Mehmi, I., Teng, P. K., Griggs, D. W., & Lupu, R. (2005) · Oncogene · doi:10.1038/sj.onc.1208238 · Cited by 154 · see citing works

Splicing Factor Tra2-β1 Is Specifically Induced in Breast Cancer and Regulates Alternative Splicing of theCD44Gene

Watermann, D. O., Tang, Y., Hausen, A. Z., Jäger, M., Stamm, S., & Stickeler, E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-04-3294 · Cited by 128 · see citing works

cDNA microarray analysis of the gene expression profile of VEGF-activated human umbilical vien endothelial cells

Abé, M., & Sato, Y. (2001) · Angiogenesis · doi:10.1023/a:1016018617152 · Cited by 123 · see citing works

The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives.

Men√©ndez, J. A., Mehmi, I., Griggs, D. W., & Lupu, R. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100141 · Cited by 120 · see citing works

Mechanisms of Hypoxic Gene Regulation of Angiogenesis Factor Cyr61 in Melanoma Cells

Kunz, M., Moeller, S., Koczan, D., Lorenz, P., Wenger, R. H., Glocker, M. O., Thiesen, H.-J., Gross, G., & Ibrahim, S. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301373200 · Cited by 104 · see citing works

CCN proteins and cancer: two to tango

Bleau, A. (2005) · Frontiers in bioscience · doi:10.2741/1594 · Cited by 97 · see citing works

Cyr61, a Member of the CCN Family, Is Required for MCF-7 Cell Proliferation: Regulation by 17 -Estradiol and Overexpression in Human Breast Cancer

Sampath, D., Winneker, R. C., & Zhang, Z. (2001) · Endocrinology · doi:10.1210/endo.142.6.8186 · Cited by 97 · see citing works

Cyr61, a deregulated gene in endometriosis

Absenger, Y. (2004) · Molecular Human Reproduction · doi:10.1093/molehr/gah053 · Cited by 95 · see citing works

Ischemia Induces a Translocation of the Splicing Factor tra2-β1 and Changes Alternative Splicing Patterns in the Brain

Daoud, R., Mies, G., Smialowska, A., Oláh, L., Hossmann, K.-A., & Stamm, S. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-14-05889.2002 · Cited by 89 · see citing works

Structural genomics analysis of alternative splicing and application to isoform structure modeling

Wang, P., Yan, B., Guo, J., Hicks, C., & Xu, Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506770102 · Cited by 67 · see citing works

Interleukin-6 is a potent inducer of S100P, which is up-regulated in androgen-refractory and metastatic prostate cancer

Hammacher, A., Thompson, E. W., & Williams, E. D. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.07.011 · Cited by 49 · see citing works

Functional domains of CCN1 (Cyr61) regulate breast cancer progression

O’Kelly, J., Chung, A. P., Lemp, N. A., Chumakova, K., Yin, D., Wang, H., SAID, J. W., Gui, D., Miller, C. W., Karlan, B. Y., et al. (2008) · International Journal of Oncology · doi:10.3892/ijo.33.1.59 · Cited by 49 · see citing works

Chromosomal mapping and expression of the human cyr61 gene in tumour cells from the nervous system.

Martinerie, C., Viégas-Pèquignot, E., Nguyen, V. C., & Perbal, B. (1997) · Molecular Pathology · doi:10.1136/mp.50.6.310 · Cited by 26 · see citing works

The Angiogenic Factor Cyr61 Is Induced by the Progestin R5020 and Is Necessary for Mammary Adenocarcinoma Cell Growth

Sampath, D., Winneker, R. C., & Zhang, Z. (2002) · Endocrine · doi:10.1385/endo:18:2:147 · Cited by 25 · see citing works

Intron 9 retention in gene transcripts suggests involvement of CD44 in the tumorigenesis of ovarian cancer.

Stickeler, E., Möbus, V. J., Kieback, D., Kohlberger, P., Runnebaum, I., & Kreienberg, R. (1997) · PubMed · Cited by 12 · see citing works

Function of alternative splicing

Stamm, S., Ben‐Ari, S., Rafalska, I., Tang, Y., Zhang, Z., Toiber, D., Thanaraj, T. A., & Soreq, H. (2004) · Gene · doi:10.1016/j.gene.2004.10.022 · Cited by 1,373 · see citing works

Function of alternative splicing

Kelemen, O., Convertini, P., Zhang, Z., Wen, Y., Shen, M., Falaleeva, M., & Stamm, S. (2013) · Gene · doi:10.1016/j.gene.2012.07.083 · Cited by 743 · see citing works

Detained introns are a novel, widespread class of post-transcriptionally spliced intronsPreprint

Boutz, P. L., Bhutkar, A. J., & Sharp, P. A. (2015) · Genes & Development · doi:10.1101/gad.247361.114 · Cited by 414 · see citing works

CCN1/CYR61: the very model of a modern matricellular protein

Lau, L. F. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0778-3 · Cited by 338 · see citing works

Site identification in high-throughput RNA–protein interaction data

Uren, P. J., Bahrami‐Samani, E., Burns, S. C., Qiao, M., Karginov, F. V., Hodges, E. C., Hannon, G. J., Sanford, J. R., Penalva, L. O. F., & Smith, A. D. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts569 · Cited by 324 · see citing works

Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer

Farina, A. R., Cappabianca, L. A., Sebastiano, M., Zelli, V., Guadagni, S., & Mackay, A. R. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01616-9 · Cited by 131 · see citing works

Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review)

Li, J., Ye, L., Owen, S., Weeks, H. P., Zhang, Z., & Jiang, W. G. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2390 · Cited by 120 · see citing works

miR-205 Expression Promotes Cell Proliferation and Migration of Human Cervical Cancer Cells

Xie, H. Y., Zhao, Y., Caramuta, S., Larsson, C., & Lui, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046990 · Cited by 117 · see citing works

Oncogenic Alternative Splicing Switches: Role in Cancer Progression and Prospects for Therapy

Bonomi, S., Gallo, S., Catillo, M., Pignataro, D. S., Biamonti, G., & Ghigna, C. (2013) · International Journal of Cell Biology · doi:10.1155/2013/962038 · Cited by 117 · see citing works

Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles

Klopfleisch, R., Lenze, D., Hummel, M., & Gruber, A. D. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-618 · Cited by 109 · see citing works

Hypoxia-Induced Alternative Splicing in Endothelial Cells

Weigand, J. E., Boeckel, J., Gellert, P., & Dimmeler, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042697 · Cited by 88 · see citing works

CCN proteins: A centralized communication network

Perbal, B. (2013) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-013-0193-7 · Cited by 90 · see citing works

Nonsense-mediated RNA decay and its bipolar function in cancer

Nogueira, G., Fernandes, R. O., García-Moreno, J. F., & Romão, L. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01364-0 · Cited by 89 · see citing works

The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis.

Zuo, G., Kohls, C. D., He, B., Chen, L., Zhang, W., Shi, Q., Zhang, B. Q., Kang, Q., Luo, J., Luo, X., et al. (2010) · PubMed · doi:10.14670/hh-25.795 · Cited by 87 · see citing works

Nuclear retention of mRNAs – quality control, gene regulation and human disease

Wegener, M., & Müller-McNicoll, M. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.11.001 · Cited by 86 · see citing works

Perspective in Alternative Splicing Coupled to Nonsense-Mediated mRNA Decay

García-Moreno, J. F., & Romão, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249424 · Cited by 83 · see citing works

Hypoxia is a Key Driver of Alternative Splicing in Human Breast Cancer Cells

Han, J., Li, J., Ho, J. C., Chia, G. S., Kato, H., Jha, S., Yang, H. H., Poellinger, L., & Lee, K. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-04333-0 · Cited by 78 · see citing works

The role of alternative splicing coupled to nonsense-mediated mRNA decay in human disease

da Costa, P. J., Menezes, J., & Romão, L. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.07.013 · Cited by 77 · see citing works

HuR Regulates Alternative Splicing of the TRA2 β Gene in Human Colon Cancer Cells under Oxidative Stress

Akaike, Y., Masuda, K., Kuwano, Y., Nishida, K., Kajita, K., Kurokawa, K., Satake, Y., Shoda, K., Imoto, I., & Rokutan, K. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00333-14 · Cited by 73 · see citing works

Sudemycin E influences alternative splicing and changes chromatin modifications

Convertini, P., Shen, M., Potter, P. M., Palacios, G. F., Lagisetti, C., de la Grange, P., Horbinski, C., Fondufe‐Mittendorf, Y. N., Webb, T. R., & Stamm, S. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku151 · Cited by 72 · see citing works

CCN1: a novel inflammation-regulated biphasic immune cell migration modulator

Löbel, M., Bauer, S., Meisel, C., Eisenreich, A., Kudernatsch, R., Tank, J., Rauch, U., Kühl, U., Schultheiß, H., Volk, H., et al. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0981-x · Cited by 68 · see citing works

Hypoxia induces immunosuppression, metastasis and drug resistance in pancreatic cancers

Zhang, H., Cao, K., Xiang, J., Zhang, M., Zhu, M., & Xi, Q. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216345 · Cited by 67 · see citing works

Physiological and pathophysiological role of nonsense-mediated mRNA decay

Ottens, F., & Gehring, N. H. (2016) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-016-1826-5 · Cited by 61 · see citing works

Hypoxia Regulates Alternative Splicing of HIF and non-HIF Target Genes

Sena, J. A., Wang, L., Heasley, L. E., & Hu, C. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0149 · Cited by 63 · see citing works

Increased Serine-Arginine (SR) Protein Phosphorylation Changes Pre-mRNA Splicing in Hypoxia

Jakubauskienė, E., Vilys, L., Makino, Y., Poellinger, L., & Kanopka, A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.639690 · Cited by 55 · see citing works

Hypoxia-induced TGF-β–RBFOX2–ESRP1 axis regulates human MENA alternative splicing and promotes EMT in breast cancer

Ahuja, N., Ashok, C., Natua, S., Pant, D., Cherian, A., Pandkar, M. R., Yadav, P., Vishnu Narayanan, S. S., Mishra, J., Samaiya, A., et al. (2020) · NAR Cancer · doi:10.1093/narcan/zcaa021 · Cited by 53 · see citing works

Post-transcriptional regulation in cancer progression

Jewer, M., Findlay, S. D., & Postovit, L.-M. M. (2012) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-012-0179-x · Cited by 51 · see citing works

Regulation of pro-angiogenic tissue factor expression in hypoxia-induced human lung cancer cells

Eisenreich, A., Zakrzewicz, A., Huber, K., THIERBACH, H., Pepke, W., Goldin-Lang, P., Schultheiß, H., Pries, A. R., & Rauch, U. (2013) · Oncology Reports · doi:10.3892/or.2013.2413 · Cited by 47 · see citing works

A novel anti-Cyr61 antibody inhibits breast cancer growth and metastasis in vivo

Lin, J., Huo, R., Wang, L., Zhou, Z., Sun, Y., Shen, B., Wang, R., & Li, N. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1135-y · Cited by 47 · see citing works

Tissue-specific splicing of ISCU results in a skeletal muscle phenotype in myopathy with lactic acidosis, while complete loss of ISCU results in early embryonic death in mice

Nordin, A., Larsson, E., Thornell, L., & Holmberg, M. (2010) · Human Genetics · doi:10.1007/s00439-010-0931-3 · Cited by 45 · see citing works

Reprogramming of m 6 A epitranscriptome is crucial for shaping of transcriptome and proteome in response to hypoxia

Wang, Y.-J., Yang, B., Lai, Q., Shi, J., Peng, J., Zhang, Y., Hu, K., Li, Y., Peng, J.-W., Yang, Z.-Z., et al. (2020) · RNA Biology · doi:10.1080/15476286.2020.1804697 · Cited by 45 · see citing works

An IgE-associated polymorphism in STAT6 alters NF-κB binding, STAT6 promoter activity, and mRNA expression

Schedel, M., Frei, R., Bieli, C., Cameron, L., Adamski, J., Lauener, R. P., & Kabesch, M. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.06.024 · Cited by 40 · see citing works

Alternative splicing of CCN mRNAs …. it has been upon us

Perbal, B. (2009) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-009-0051-9 · Cited by 40 · see citing works

Balance between MAT2A intron detention and splicing is determined cotranscriptionally

Pendleton, K. E., Park, S.-K., Hunter, O. V., Bresson, S. M., & Conrad, N. K. (2018) · RNA · doi:10.1261/rna.064899.117 · Cited by 37 · see citing works

The Roles of CCN1/CYR61 in Pulmonary Diseases

Zhu, Y., Almuntashiri, S., Han, Y., Wang, X., Somanath, P. R., & Zhang, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217810 · Cited by 35 · see citing works

Nuclear co-localization and functional interaction of COX-2 and HIF-1α characterize bone metastasis of human breast carcinoma

Maroni, P., Matteucci, E., Luzzati, A., Perrucchini, G. G., Bendinelli, P., & Desiderio, M. A. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1240-1 · Cited by 36 · see citing works

CCN3 modulates bone turnover and is a novel regulator of skeletal metastasis

Ouellet, V., & Siegel, P. M. (2012) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-012-0161-7 · Cited by 36 · see citing works

Hypoxia-driven splicing into noncoding isoforms regulates the DNA damage response

Memon, D., Dawson, K., Smowton, C., Wei, X., Dive, C., & Miller, C. J. (2016) · npj Genomic Medicine · doi:10.1038/npjgenmed.2016.20 · Cited by 34 · see citing works

Cysteine‐rich protein 61 (CCN1) and connective tissue growth factor (CCN2) at the crosshairs of ocular neovascular and fibrovascular disease therapy

Yan, L., & Chaqour, B. (2013) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-013-0206-6 · Cited by 34 · see citing works

Hypoxia-induced changes in intragenic DNA methylation correlate with alternative splicing in breast cancer

Pant, D., Narayanan, S. P., Vijay, N., & Shukla, S. (2020) · Journal of Biosciences · doi:10.1007/s12038-019-9977-0 · Cited by 32 · see citing works

Hypoxia‐dependent mRNA expression pattern of splicing factor YT521 and its impact on oncological important target gene expression

Hirschfeld, M., Zhang, B., Jaeger, M., Stamm, S., Erbes, T., Mayer, S., Tong, X., & Stickeler, E. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22045 · Cited by 33 · see citing works

Alternative Splicing-Related Factor YT521

Zhang, B., Hausen, A. Z., Orlowska‐Volk, M., Jäger, M., Bettendorf, H., Stamm, S., Hirschfeld, M., Yiqin, O., Tong, X., Gitsch, G., et al. (2010) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181d66ffe · Cited by 28 · see citing works

Expression levels of hnRNP G and hTra2‐beta1 correlate with opposite outcomes in endometrial cancer biology

Ouyang, Y. Q., Hausen, A. Z., Orlowska‐Volk, M., Jäger, M., Bettendorf, H., Hirschfeld, M., Tong, X. W., & Stickeler, E. (2010) · International Journal of Cancer · doi:10.1002/ijc.25544 · Cited by 26 · see citing works

Cell survival: Interplay between hypoxia and pre-mRNA splicing

Kanopka, A. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.03.018 · Cited by 26 · see citing works

Hydrogen Peroxide Alters Splicing of Soluble Guanylyl Cyclase and Selectively Modulates Expression of Splicing Regulators in Human Cancer Cells

Cote, G. J., Zhu, W., Thomas, A., Martin, E., Murad, F., & Sharina, I. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041099 · Cited by 23 · see citing works

Use of patient derived urine renal epithelial cells to confirm pathogenicity of PKHD1 alleles

Molinari, E., Srivastava, S., Dewhurst, R. M., & Sayer, J. A. (2020) · BMC Nephrology · doi:10.1186/s12882-020-02094-z · Cited by 23 · see citing works

Hypoxia-induced alternative splicing in human diseases: the pledge, the turn, and the prestige

Natua, S., Ashok, C., & Shukla, S. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03727-0 · Cited by 22 · see citing works

CCN1 Suppresses Pulmonary Vascular Smooth Muscle Contraction in Response to Hypoxia

Lee, S., Zhang, M., Hu, K., Lin, L., Zhang, D., & Jin, Y. (2015) · Pulmonary Circulation · doi:10.1086/683812 · Cited by 21 · see citing works

Alternative Splicing and Hypoxia Puzzle in Alzheimer’s and Parkinson’s Diseases

Jakubauskienė, E., & Kanopka, A. (2021) · Genes · doi:10.3390/genes12081272 · Cited by 19 · see citing works

Cysteine-rich 61 (CYR61) is up-regulated in proliferative diabetic retinopathy

Zhang, X., Yu, W., & Dong, F.-T. (2011) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-011-1882-7 · Cited by 19 · see citing works

Small molecule inhibition of cytoskeletal dynamics in melanoma tumors results in altered transcriptional expression patterns of key genes involved in tumor initiation and progression.

Spencer, C., Montalvo, J., McLaughlin, S. R., & Bryan, B. A. (2011) · PubMed · Cited by 19 · see citing works

Dysregulation of splicing variants and spliceosome components in breast cancer

Gahete, M. D., Hermán‐Sánchez, N., Fuentes-Fayos, A. C., Lopez-Canovas, J. L., & Luque, R. M. (2022) · Endocrine Related Cancer · doi:10.1530/erc-22-0019 · Cited by 19 · see citing works

Mesenchymal stem cell contact promotes CCN1 splicing and transcription in myeloma cells

Dotterweich, J., Ebert, R., Kraus, S., Tower, R. J., Jakob, F. J., & Schütze, N. (2014) · Cell Communication and Signaling · doi:10.1186/1478-811x-12-36 · Cited by 17 · see citing works

Expression of tumor-promoting Cyr61 is regulated by hTRA2- 1 and acidosis

Hirschfeld, M., Jaeger, M., Buratti, E., Stuani, C., Grueneisen, J. S., Gitsch, G., & Stickeler, E. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr128 · Cited by 16 · see citing works

Oxygen regulates molecular mechanisms of cancer progression and metastasis

Gupta, K., Madan, E., Sayyid, M. M., Arias‐Pulido, H., Moreno, E., Kuppusamy, P., & Gogna, R. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9464-2 · Cited by 15 · see citing works

A novel anti-CCN1 monoclonal antibody suppresses Rac-dependent cytoskeletal reorganization and migratory activities in breast cancer cells

Leu, S.-J. J., Sung, J.-S., Huang, M.-L., Chen, M., & Tsai, T.-W. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.04.045 · Cited by 14 · see citing works

Mapping Extracellular Protein–Protein Interactions Using Extracellular Proximity Labeling (ePL)

Peeney, D., Gurung, S., Rich, J. A., Coates-Park, S., Liu, Y., Toor, J., Jones, J., Richie, C. T., Jenkins, L. M., & Stetler-Stevenson, W. G. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00606 · Cited by 13 · see citing works

Insights into Muscle Degeneration from Heritable Inclusion Body Myopathies

Krause, S. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00013 · Cited by 13 · see citing works

Cysteine-Rich Angiogenic Inducer 61: Pro-Survival Function and Role as a Biomarker for Disseminating Breast Cancer Cells

Bartkowiak, K., Heidrich, I., Kwiatkowski, M., Gorges, T. M., Andreas, A., Geffken, M., Verpoort, K., Müller, V., Schlüter, H., & Pantel, K. (2021) · Cancers · doi:10.3390/cancers13030563 · Cited by 14 · see citing works

Investigating Microenvironmental Regulation of Human Chordoma Cell Behaviour

Patel, P., Brooks, C. R., Seneviratne, A. K., Hess, D. A., & Séguin, C. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115909 · Cited by 11 · see citing works

Reduced NOV expression correlates with disease progression in colorectal cancer and is associated with survival, invasion and chemoresistance of cancer cells

Li, J., Ye, L., Sun, P., Zheng, F., Ruge, F., Satherley, L. K., Feng, Y., Zhao, H., Du, G., Wang, T., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15439 · Cited by 10 · see citing works

Clinical relevance of Cyr61 expression in patients with hormone-dependent breast cancer

Mayer, S., Erbes, T., Timme‐Bronsert, S., Jaeger, M., Rücker, G., Kuf, F., Stickeler, E., Gitsch, G., & Hirschfeld, M. (2017) · Oncology Letters · doi:10.3892/ol.2017.6406 · Cited by 9 · see citing works

U2AF - Hypoxia-induced fas alternative splicing regulator

Vilys, L., Pečiulienė, I., Jakubauskienė, E., Zinkevičiūtė, R., Makino, Y., & Kanopka, A. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112444 · Cited by 9 · see citing works

Nonsense-mediated mRNA decay: a key regulatory system engaged in cancer

Pan, H., Wu, X., Hu, B., Xiong, H., Luo, Y., & Zhou, J. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02503-6 · Cited by 8 · see citing works

Hypoxia-Associated Alternative Splicing Signature in Lung Adenocarcinoma

Xu, Z., Wei, J., Qin, F., Sun, Y., Xiang, W., Yuan, L., Qin, J., Deng, K., Zheng, T., & Li, S. (2020) · Epigenomics · doi:10.2217/epi-2020-0399 · Cited by 9 · see citing works

Alternative Splicing in Prostate and Breast Cancer

Watson, P. M., & Watson, D. K. (2010) · The Open Cancer Journal · doi:10.2174/1874079001003010062 · Cited by 8 · see citing works

Post-transcriptional Regulation of Gene Expression via Unproductive Splicing

Zavileyskiy, L. G., & Pervouchine, D. D. (2024) · Acta Naturae · doi:10.32607/actanaturae.27337 · Cited by 7 · see citing works

Mutations in LAMA2 and CAPN3 genes associated with genetic and phenotypic heterogeneities within a single consanguineous family involving both congenital and progressive muscular dystrophies

Salem, I. H., Kamoun, F. F., Louhichi, N., Rouis, S., Mziou, M., Fendri-Kriaa, N., Ayadi, F. M., Triki, C., & Fakhfakh, F. (2010) · Bioscience Reports · doi:10.1042/bsr20100026 · Cited by 7 · see citing works

Novel CT domain-encoding splice forms of CTGF/CCN2 are expressed in B-lineage acute lymphoblastic leukaemia

Welch, M. D., Howlett, M., Halse, H. M., Greene, W. K., & Kees, U. R. (2015) · Leukemia Research · doi:10.1016/j.leukres.2015.05.008 · Cited by 6 · see citing works

Maternal western-style diet enhances the effects of chemically-induced mammary tumors in female rat offspring through transcriptome changes

Grassi, T. F., Bidinotto, L. T., Lopes, G. A. D., Zapaterini, J. R., Rodrigues, M. A. M., & Barbisan, L. F. (2018) · Nutrition Research · doi:10.1016/j.nutres.2018.09.009 · Cited by 6 · see citing works

Modulation of the isoform expression of Cyr61 and Integrin-αv in human microvascular endothelial cells

Gauck, S., Schultheiß, H., Rauch, U., & Eisenreich, A. (2013) · Cardiovascular System · doi:10.7243/2052-4358-1-8 · Cited by 5 · see citing works

CYR61 Expression Is Induced by IGF1 and Promotes the Proliferation of Prostate Cancer Cells Through the PI3/AKT Signaling Pathway

Ortiz-Hernández, G. L., Patrick, C. S., Hinz, S., LaBarge, M. A., Li, Y. R., & Neuhausen, S. L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188991 · Cited by 3 · see citing works

Resistance to antiangiogenic treatments: A review

Koltai, T., Reshkin, S. J., & Cardone, R. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90190-1.00014-7 · Cited by 3 · see citing works

The Potential of Targeting Splicing for Cancer Therapy

Grosso, A. R., & Carmo‐Fonseca, M. (2013) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-8039-6_13 · Cited by 3 · see citing works

Polymorphisms of the CYR61 gene in patients with acute myeloid leukemia in a Han Chinese population

Niu, C., Wan, Y., Yang, C., Li, T., & Liao, P. (2018) · Medicine · doi:10.1097/md.0000000000011963 · Cited by 2 · see citing works

What’s in an intron? CCN1 mRNA splicing in cancer

Leask, A. (2009) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-009-0050-x · Cited by 2 · see citing works

Alternative Splicing and Human Disease

Stamm, S. (2017) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0021435.pub2 · Cited by 2 · see citing works

Basic science: (March 2009)

Sutherland, R. L. (2009) · Breast Cancer Online · doi:10.1017/s1470903109990216

References

(2011) · Elsevier eBooks · doi:10.1016/b978-0-12-387819-9.00029-3

Hypoxia-initiated Cysteine-rich protein 61 secretion promotes chemoresistance of acute B lymphoblastic leukemia cells

Li, Z. (2024) · American Journal of Cancer Research · doi:10.62347/ckmt4065

Additional file 1 of Use of patient derived urine renal epithelial cells to confirm pathogenicity of PKHD1 alleles

Molinari, E., Srivastava, S., Dewhurst, R. M., & Sayer, J. A. (2020) · Figshare · doi:10.6084/m9.figshare.13100986

Composition et dynamique des complexes protéiques impliqués dans le "nonsense-mediated mRNA decay" chez la levure Saccharomyces cerevisiae

Dehecq, M. (2018) · theses.fr (ABES) · doi:10.70675/61bd4108zec99z4471z8a6ez2454d54bdfa3

The extended Split-ORF pipeline: Prediction and evaluation of Split-ORFs using Ribo-seq dataPreprint

Kalk, C., Murtagh, J., Despic, V., Müller-McNicoll, M., & Schulz, M. H. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.22.727176

Alternative splicing rewires breast cancer and opens therapeutic avenues

Jin, Y., Liang, Y., Kasvaei, M. M., & Yang, Q. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-03017-5 · Cited by 1 · see citing works

Matricellular Proteins in Bladder Cancer: Context-Dependent Roles in Tumor Promotion and Suppression

Akhmetkaliyev, A., García, J. H. G. F., Sonnenberg-Riethmacher, E., & Riethmacher, D. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27156807

Targeting SUV39H2 exon skipping reverses resistance to CDK4/6 inhibitors via transcriptional activation of p21

Yu, S., Gong, X. Q., Yang, Y., Duan, Y., Zhang, S., Wang, Y., Wang, Z., Bi, C., & Sun, H. (2026) · Science Advances · doi:10.1126/sciadv.aea2001

Alternative splicing of human CYR61 (CCN1) originates from intron retention and splicing pattern is altered by hypoxia

Hirschfeld, M., Jäger, M., & Stickeler, E. (2008) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0028-1088706

Alternatives Spleißen von Cyr61 wird reguliert durch Hypoxie und ist signifikant verändert bei Brustkrebs

Hirschfeld, M., Hausen, A. Z., Jäger, M., & Stickeler, E. (2008) · Senologie - Zeitschrift für Mammadiagnostik und -therapie · doi:10.1055/s-0028-1096030

Expression of tumor-promoting Cyr61 is regulated by hTRA2- 1 and acidosis

Hirschfeld, M., Jaeger, M., Buratti, E., Stuani, C., Grueneisen, J. S., Gitsch, G., & Stickeler, E. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr128 · Cited by 16 · see citing works

Mechanisms of Hypoxic Gene Regulation of Angiogenesis Factor Cyr61 in Melanoma Cells

Kunz, M., Moeller, S., Koczan, D., Lorenz, P., Wenger, R. H., Glocker, M. O., Thiesen, H.-J., Gross, G., & Ibrahim, S. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301373200 · Cited by 104 · see citing works

Hypoxia is a Key Driver of Alternative Splicing in Human Breast Cancer Cells

Han, J., Li, J., Ho, J. C., Chia, G. S., Kato, H., Jha, S., Yang, H. H., Poellinger, L., & Lee, K. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-04333-0 · Cited by 78 · see citing works